BMC Cancer
Journal Abbreviation: BMC CANCER
ISSN: 1471-2407
Publisher: BioMed Central
Publications (98)
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy (2022)
Leichsenring J, Vladimirova V, Solbach C, Karn T, Ataseven B, Sinn BV, Barinoff J, et al.
Journal article
Metabolic alterations in meningioma reflect the clinical course (2021)
Masalha W, Daka K, Woerner J, Pompe N, Weber S, Delev D, Krüger MT, et al.
Journal article
Soft tissue masses: distribution of entities and rate of malignancy in small lesions (2021)
Gassert FG, Gassert FT, Specht K, Knebel C, Lenze U, Makowski MR, Von Eisenhart-Rothe R, et al.
Journal article
Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival (2021)
Voglhuber T, Eitz KA, Oechsner M, Vogel MME, Combs SE
Journal article
Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer (BMC Cancer, (2021), 21, 1, (920), 10.1186/s12885-021-08656-0) (2021)
Stuerken C, Moebus V, Milde-Langosch K, Schmatloch S, Fasching P, Rueschoff J, Stickeler E, et al.
Journal article, Erratum
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors (2021)
Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, et al.
Journal article
Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP) (2021)
Balk M, Rupp R, Mantsopoulos K, Allner M, Grundtner P, Müller-Hübner SKU, Traxdorf M, et al.
Journal article
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer (2021)
Stuerken C, Moebus V, Milde-Langosch K, Schmatloch S, Fasching P, Rueschoff J, Stickeler E, et al.
Journal article
Intraventricular neuroepithelial tumors: surgical outcome, technical considerations and review of literature (2020)
Aftahy AK, Barz M, Krauss P, Liesche F, Wiestler B, Combs SE, Straube C, et al.
Journal article
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany (2020)
Hübner H, Kurbacher CM, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al.
Journal article